Does gene reading different then PACB and Illumina...
Cytogenomics instead of base pair reading
Basically no revenues yet but $2B market cap now...
Still looks like a great future..
I bought in 1's when the hype started and sold it all out recently since expensive now.
Despite minimal revenues, could be a buyout by Illumina for their tech since it would help with their weaknesses in gene sequencing.
But I sold because didnt want to wait or bet on buyout or revenues after such a good run.